0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Trihexyphenidyl Market Research Report 2026
Published Date: 2026-03-14
|
Report Code: QYRE-Auto-0O17843
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Trihexyphenidyl Market Research Report 2024
BUY CHAPTERS

Global Trihexyphenidyl Market Research Report 2026

Code: QYRE-Auto-0O17843
Report
2026-03-14
Pages:145
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Trihexyphenidyl Market Size

The global Trihexyphenidyl market was valued at US$ 67.27 million in 2025 and is anticipated to reach US$ 83.6 million by 2032, at a CAGR of 3.2% from 2026 to 2032.

Trihexyphenidyl Market

Trihexyphenidyl Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Trihexyphenidyl competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2024, the global production of trihexyphenidyl is 9.556 million pieces, with an average price of US$6.88 per piece.
Trihexyphenidyl is a commonly used anticholinergic drug with specific application value in the treatment of neurological diseases. It primarily works by blocking M cholinergic receptors in the central nervous system and peripheral tissues. Blockade of central M cholinergic receptors is particularly critical, regulating the balance between cholinergic and dopaminergic nerves in the central nervous system. When dopaminergic function is weakened and cholinergic function is relatively hyperactive, trihexyphenidyl can inhibit cholinergic overactivity, thereby improving the symptoms of movement disorders caused by this. It also blocks M cholinergic receptors in the periphery, but the effect is weaker than that of drugs such as atropine, resulting in only mild peripheral anticholinergic reactions.
Industry Chain
As a pharmaceutical product, its upstream supply chain includes the organic chemical intermediates, solvents, and API synthesis processes and equipment required for synthesis. The midstream includes trihexyphenidyl/trihexyphenidyl hydrochloride API manufacturers, GMP laboratories, and related quality control. The downstream sector primarily comprises pharmaceutical manufacturers, generic/branded drug distribution channels, hospitals, and retail pharmacies. Ultimately, drug usage is driven by prescribing practices in neurology and psychiatry, as well as clinical needs for Parkinson's disease and antipsychotic-induced extrapyramidal reactions. Therefore, the supply stability and compliance of upstream raw materials and midstream APIs directly impact downstream pharmaceutical manufacturers and hospital procurement and clinical supply.
Industry Policies
As a prescription drug, trihexyphenidyl is subject to regulatory requirements (e.g., drug registration/approval, GMP, and prescription drug sales and advertising restrictions). In major markets such as the United States, the European Union, and China, these approvals and prescription management determine market access and distribution patterns. (Historically, trihexyphenidyl's approval and clinical use in different countries are well documented.) Development Trends
Global aging and the significant increase in Parkinson's disease prevalence will continue to drive demand for primary care medications to combat Parkinson's symptoms. (The World Health Organization and recent epidemiological and predictive studies indicate that the number of Parkinson's patients has increased significantly over the past few decades and is expected to continue to rise in the coming decades.) At the same time, new long-acting, gene/cell therapies, and disease-modifying drugs are emerging in the field of neurodegenerative diseases. This not only provides a stable base market for symptom-modifying drugs, but also creates new competition and opportunities for these small molecule drugs in terms of product differentiation, dosing convenience, and combination therapy strategies. Market opportunities primarily stem from the growth in the medication base driven by aging regional populations and increased diagnosis rates; the development of better-tolerated or extended-release formulations to meet long-term clinical management needs; the potential for generics and improved accessibility in developing countries and low- and middle-income regions; and the demand for complementary medications for the management of extrapyramidal reactions in psychiatric settings. Obstacles and challenges include: partial replacement of overall efficacy by drugs such as levodopa and emerging treatments, drug side effects (anticholinergic side effects are of particular concern in the elderly), drug regulation and pricing pressure, and rising costs of API raw materials and production compliance.
Gross Profit Margins
There are significant differences between original and generic drugs. For example, in the US market, the gross profit margin for original branded benzhexol can reach 70%-80%, primarily due to patent protection and brand premiums. However, under the volume-based procurement policy, generic drug prices have dropped by an average of 52%, compressing gross profit margins to 30%-50%.
This report delivers a comprehensive overview of the global Trihexyphenidyl market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Trihexyphenidyl. The Trihexyphenidyl market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Trihexyphenidyl market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Trihexyphenidyl manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Trihexyphenidyl Market Report

Report Metric Details
Report Name Trihexyphenidyl Market
Accounted market size in 2025 US$ 67.27 million
Forecasted market size in 2032 US$ 83.6 million
CAGR 3.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • 2mg
  • 5mg
by Application
  • Hospital
  • Pharmacy
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Natco Pharma, Kawaken Fine Chemical, Asia Pioneer Pharmaceuticals, Olon, Anugraha Chemicals, RL Fine Chem, Trifarma, Atom pharma, Amitychem, Hunan Zhongnan Pharmaceutical中南制药, Changzhou Kangpu Pharmaceutical, Swiss Parenterals, Enomark, Fengchen Group, Sandoo Pharmaceuticals and Chemicals, Midas Pharma, Conscientia Industrial, Huateng Pharma, Daffohils Laboratories, Senova Technology, Fortunebio Pharmaceuticals, Taj Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Trihexyphenidyl manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Trihexyphenidyl sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Trihexyphenidyl Market growing?

Ans: The Trihexyphenidyl Market witnessing a CAGR of 3.2% during the forecast period 2026-2032.

What is the Trihexyphenidyl Market size in 2032?

Ans: The Trihexyphenidyl Market size in 2032 will be US$ 83.6 million.

Who are the main players in the Trihexyphenidyl Market report?

Ans: The main players in the Trihexyphenidyl Market are Natco Pharma, Kawaken Fine Chemical, Asia Pioneer Pharmaceuticals, Olon, Anugraha Chemicals, RL Fine Chem, Trifarma, Atom pharma, Amitychem, Hunan Zhongnan Pharmaceutical中南制药, Changzhou Kangpu Pharmaceutical, Swiss Parenterals, Enomark, Fengchen Group, Sandoo Pharmaceuticals and Chemicals, Midas Pharma, Conscientia Industrial, Huateng Pharma, Daffohils Laboratories, Senova Technology, Fortunebio Pharmaceuticals, Taj Pharmaceuticals

What are the Application segmentation covered in the Trihexyphenidyl Market report?

Ans: The Applications covered in the Trihexyphenidyl Market report are Hospital, Pharmacy, Clinic

What are the Type segmentation covered in the Trihexyphenidyl Market report?

Ans: The Types covered in the Trihexyphenidyl Market report are 2mg, 5mg

1 Trihexyphenidyl Market Overview
1.1 Product Definition
1.2 Trihexyphenidyl by Type
1.2.1 Global Trihexyphenidyl Market Value by Type: 2025 vs 2032
1.2.2 2mg
1.2.3 5mg
1.3 Trihexyphenidyl by Application
1.3.1 Global Trihexyphenidyl Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Clinic
1.4 Global Trihexyphenidyl Market Size Estimates and Forecasts
1.4.1 Global Trihexyphenidyl Revenue 2021–2032
1.4.2 Global Trihexyphenidyl Sales 2021–2032
1.4.3 Global Trihexyphenidyl Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Trihexyphenidyl Market Competition by Manufacturers
2.1 Global Trihexyphenidyl Sales Market Share by Manufacturers (2021–2026)
2.2 Global Trihexyphenidyl Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Trihexyphenidyl Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Trihexyphenidyl, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Trihexyphenidyl, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Trihexyphenidyl, Product Types and Applications
2.7 Global Key Manufacturers of Trihexyphenidyl, Date of Entry into the Industry
2.8 Global Trihexyphenidyl Market Competitive Situation and Trends
2.8.1 Global Trihexyphenidyl Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Trihexyphenidyl Players Market Share by Revenue
2.8.3 Global Trihexyphenidyl Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Trihexyphenidyl Market Scenario by Region
3.1 Global Trihexyphenidyl Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Trihexyphenidyl Sales by Region: 2021–2032
3.2.1 Global Trihexyphenidyl Sales by Region: 2021–2026
3.2.2 Global Trihexyphenidyl Sales by Region: 2027–2032
3.3 Global Trihexyphenidyl Revenue by Region: 2021–2032
3.3.1 Global Trihexyphenidyl Revenue by Region: 2021–2026
3.3.2 Global Trihexyphenidyl Revenue by Region: 2027–2032
3.4 North America Trihexyphenidyl Market Facts & Figures by Country
3.4.1 North America Trihexyphenidyl Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Trihexyphenidyl Sales by Country (2021–2032)
3.4.3 North America Trihexyphenidyl Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Trihexyphenidyl Market Facts & Figures by Country
3.5.1 Europe Trihexyphenidyl Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Trihexyphenidyl Sales by Country (2021–2032)
3.5.3 Europe Trihexyphenidyl Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Trihexyphenidyl Market Facts & Figures by Region
3.6.1 Asia Pacific Trihexyphenidyl Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Trihexyphenidyl Sales by Region (2021–2032)
3.6.3 Asia Pacific Trihexyphenidyl Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Trihexyphenidyl Market Facts & Figures by Country
3.7.1 Latin America Trihexyphenidyl Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Trihexyphenidyl Sales by Country (2021–2032)
3.7.3 Latin America Trihexyphenidyl Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Trihexyphenidyl Market Facts & Figures by Country
3.8.1 Middle East and Africa Trihexyphenidyl Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Trihexyphenidyl Sales by Country (2021–2032)
3.8.3 Middle East and Africa Trihexyphenidyl Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Trihexyphenidyl Sales by Type (2021–2032)
4.1.1 Global Trihexyphenidyl Sales by Type (2021–2026)
4.1.2 Global Trihexyphenidyl Sales by Type (2027–2032)
4.1.3 Global Trihexyphenidyl Sales Market Share by Type (2021–2032)
4.2 Global Trihexyphenidyl Revenue by Type (2021–2032)
4.2.1 Global Trihexyphenidyl Revenue by Type (2021–2026)
4.2.2 Global Trihexyphenidyl Revenue by Type (2027–2032)
4.2.3 Global Trihexyphenidyl Revenue Market Share by Type (2021–2032)
4.3 Global Trihexyphenidyl Price by Type (2021–2032)
5 Segment by Application
5.1 Global Trihexyphenidyl Sales by Application (2021–2032)
5.1.1 Global Trihexyphenidyl Sales by Application (2021–2026)
5.1.2 Global Trihexyphenidyl Sales by Application (2027–2032)
5.1.3 Global Trihexyphenidyl Sales Market Share by Application (2021–2032)
5.2 Global Trihexyphenidyl Revenue by Application (2021–2032)
5.2.1 Global Trihexyphenidyl Revenue by Application (2021–2026)
5.2.2 Global Trihexyphenidyl Revenue by Application (2027–2032)
5.2.3 Global Trihexyphenidyl Revenue Market Share by Application (2021–2032)
5.3 Global Trihexyphenidyl Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Natco Pharma
6.1.1 Natco Pharma Company Information
6.1.2 Natco Pharma Description and Business Overview
6.1.3 Natco Pharma Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Natco Pharma Trihexyphenidyl Product Portfolio
6.1.5 Natco Pharma Recent Developments/Updates
6.2 Kawaken Fine Chemical
6.2.1 Kawaken Fine Chemical Company Information
6.2.2 Kawaken Fine Chemical Description and Business Overview
6.2.3 Kawaken Fine Chemical Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Kawaken Fine Chemical Trihexyphenidyl Product Portfolio
6.2.5 Kawaken Fine Chemical Recent Developments/Updates
6.3 Asia Pioneer Pharmaceuticals
6.3.1 Asia Pioneer Pharmaceuticals Company Information
6.3.2 Asia Pioneer Pharmaceuticals Description and Business Overview
6.3.3 Asia Pioneer Pharmaceuticals Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Asia Pioneer Pharmaceuticals Trihexyphenidyl Product Portfolio
6.3.5 Asia Pioneer Pharmaceuticals Recent Developments/Updates
6.4 Olon
6.4.1 Olon Company Information
6.4.2 Olon Description and Business Overview
6.4.3 Olon Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Olon Trihexyphenidyl Product Portfolio
6.4.5 Olon Recent Developments/Updates
6.5 Anugraha Chemicals
6.5.1 Anugraha Chemicals Company Information
6.5.2 Anugraha Chemicals Description and Business Overview
6.5.3 Anugraha Chemicals Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Anugraha Chemicals Trihexyphenidyl Product Portfolio
6.5.5 Anugraha Chemicals Recent Developments/Updates
6.6 RL Fine Chem
6.6.1 RL Fine Chem Company Information
6.6.2 RL Fine Chem Description and Business Overview
6.6.3 RL Fine Chem Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 RL Fine Chem Trihexyphenidyl Product Portfolio
6.6.5 RL Fine Chem Recent Developments/Updates
6.7 Trifarma
6.7.1 Trifarma Company Information
6.7.2 Trifarma Description and Business Overview
6.7.3 Trifarma Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Trifarma Trihexyphenidyl Product Portfolio
6.7.5 Trifarma Recent Developments/Updates
6.8 Atom pharma
6.8.1 Atom pharma Company Information
6.8.2 Atom pharma Description and Business Overview
6.8.3 Atom pharma Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Atom pharma Trihexyphenidyl Product Portfolio
6.8.5 Atom pharma Recent Developments/Updates
6.9 Amitychem
6.9.1 Amitychem Company Information
6.9.2 Amitychem Description and Business Overview
6.9.3 Amitychem Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Amitychem Trihexyphenidyl Product Portfolio
6.9.5 Amitychem Recent Developments/Updates
6.10 Hunan Zhongnan Pharmaceutical中南制药
6.10.1 Hunan Zhongnan Pharmaceutical中南制药 Company Information
6.10.2 Hunan Zhongnan Pharmaceutical中南制药 Description and Business Overview
6.10.3 Hunan Zhongnan Pharmaceutical中南制药 Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Hunan Zhongnan Pharmaceutical中南制药 Trihexyphenidyl Product Portfolio
6.10.5 Hunan Zhongnan Pharmaceutical中南制药 Recent Developments/Updates
6.11 Changzhou Kangpu Pharmaceutical
6.11.1 Changzhou Kangpu Pharmaceutical Company Information
6.11.2 Changzhou Kangpu Pharmaceutical Description and Business Overview
6.11.3 Changzhou Kangpu Pharmaceutical Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Changzhou Kangpu Pharmaceutical Trihexyphenidyl Product Portfolio
6.11.5 Changzhou Kangpu Pharmaceutical Recent Developments/Updates
6.12 Swiss Parenterals
6.12.1 Swiss Parenterals Company Information
6.12.2 Swiss Parenterals Description and Business Overview
6.12.3 Swiss Parenterals Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Swiss Parenterals Trihexyphenidyl Product Portfolio
6.12.5 Swiss Parenterals Recent Developments/Updates
6.13 Enomark
6.13.1 Enomark Company Information
6.13.2 Enomark Description and Business Overview
6.13.3 Enomark Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Enomark Trihexyphenidyl Product Portfolio
6.13.5 Enomark Recent Developments/Updates
6.14 Fengchen Group
6.14.1 Fengchen Group Company Information
6.14.2 Fengchen Group Description and Business Overview
6.14.3 Fengchen Group Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Fengchen Group Trihexyphenidyl Product Portfolio
6.14.5 Fengchen Group Recent Developments/Updates
6.15 Sandoo Pharmaceuticals and Chemicals
6.15.1 Sandoo Pharmaceuticals and Chemicals Company Information
6.15.2 Sandoo Pharmaceuticals and Chemicals Description and Business Overview
6.15.3 Sandoo Pharmaceuticals and Chemicals Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Sandoo Pharmaceuticals and Chemicals Trihexyphenidyl Product Portfolio
6.15.5 Sandoo Pharmaceuticals and Chemicals Recent Developments/Updates
6.16 Midas Pharma
6.16.1 Midas Pharma Company Information
6.16.2 Midas Pharma Description and Business Overview
6.16.3 Midas Pharma Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Midas Pharma Trihexyphenidyl Product Portfolio
6.16.5 Midas Pharma Recent Developments/Updates
6.17 Conscientia Industrial
6.17.1 Conscientia Industrial Company Information
6.17.2 Conscientia Industrial Description and Business Overview
6.17.3 Conscientia Industrial Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Conscientia Industrial Trihexyphenidyl Product Portfolio
6.17.5 Conscientia Industrial Recent Developments/Updates
6.18 Huateng Pharma
6.18.1 Huateng Pharma Company Information
6.18.2 Huateng Pharma Description and Business Overview
6.18.3 Huateng Pharma Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Huateng Pharma Trihexyphenidyl Product Portfolio
6.18.5 Huateng Pharma Recent Developments/Updates
6.19 Daffohils Laboratories
6.19.1 Daffohils Laboratories Company Information
6.19.2 Daffohils Laboratories Description and Business Overview
6.19.3 Daffohils Laboratories Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Daffohils Laboratories Trihexyphenidyl Product Portfolio
6.19.5 Daffohils Laboratories Recent Developments/Updates
6.20 Senova Technology
6.20.1 Senova Technology Company Information
6.20.2 Senova Technology Description and Business Overview
6.20.3 Senova Technology Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Senova Technology Trihexyphenidyl Product Portfolio
6.20.5 Senova Technology Recent Developments/Updates
6.21 Fortunebio Pharmaceuticals
6.21.1 Fortunebio Pharmaceuticals Company Information
6.21.2 Fortunebio Pharmaceuticals Description and Business Overview
6.21.3 Fortunebio Pharmaceuticals Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Fortunebio Pharmaceuticals Trihexyphenidyl Product Portfolio
6.21.5 Fortunebio Pharmaceuticals Recent Developments/Updates
6.22 Taj Pharmaceuticals
6.22.1 Taj Pharmaceuticals Company Information
6.22.2 Taj Pharmaceuticals Description and Business Overview
6.22.3 Taj Pharmaceuticals Trihexyphenidyl Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Taj Pharmaceuticals Trihexyphenidyl Product Portfolio
6.22.5 Taj Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Trihexyphenidyl Industry Chain Analysis
7.2 Trihexyphenidyl Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Trihexyphenidyl Production Mode & Process Analysis
7.4 Trihexyphenidyl Sales and Marketing
7.4.1 Trihexyphenidyl Sales Channels
7.4.2 Trihexyphenidyl Distributors
7.5 Trihexyphenidyl Customer Analysis
8 Trihexyphenidyl Market Dynamics
8.1 Trihexyphenidyl Industry Trends
8.2 Trihexyphenidyl Market Drivers
8.3 Trihexyphenidyl Market Challenges
8.4 Trihexyphenidyl Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Trihexyphenidyl Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Trihexyphenidyl Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Trihexyphenidyl Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Trihexyphenidyl Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Trihexyphenidyl Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Trihexyphenidyl Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Trihexyphenidyl Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Trihexyphenidyl Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Trihexyphenidyl, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Trihexyphenidyl, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Trihexyphenidyl, Product Types and Applications
 Table 12. Global Key Manufacturers of Trihexyphenidyl, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Trihexyphenidyl Companies by Tier (Tier 1, Tier 2, Tier 3), based on Trihexyphenidyl Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Trihexyphenidyl Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Trihexyphenidyl Sales by Region (K Units), 2021–2026
 Table 18. Global Trihexyphenidyl Sales Market Share by Region (2021–2026)
 Table 19. Global Trihexyphenidyl Sales by Region (K Units), 2027–2032
 Table 20. Global Trihexyphenidyl Sales Market Share by Region (2027–2032)
 Table 21. Global Trihexyphenidyl Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Trihexyphenidyl Revenue Market Share by Region (2021–2026)
 Table 23. Global Trihexyphenidyl Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Trihexyphenidyl Revenue Market Share by Region (2027–2032)
 Table 25. North America Trihexyphenidyl Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Trihexyphenidyl Sales by Country (K Units), 2021–2026
 Table 27. North America Trihexyphenidyl Sales by Country (K Units), 2027–2032
 Table 28. North America Trihexyphenidyl Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Trihexyphenidyl Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Trihexyphenidyl Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Trihexyphenidyl Sales by Country (K Units), 2021–2026
 Table 32. Europe Trihexyphenidyl Sales by Country (K Units), 2027–2032
 Table 33. Europe Trihexyphenidyl Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Trihexyphenidyl Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Trihexyphenidyl Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Trihexyphenidyl Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Trihexyphenidyl Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Trihexyphenidyl Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Trihexyphenidyl Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Trihexyphenidyl Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Trihexyphenidyl Sales by Country (K Units), 2021–2026
 Table 42. Latin America Trihexyphenidyl Sales by Country (K Units), 2027–2032
 Table 43. Latin America Trihexyphenidyl Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Trihexyphenidyl Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Trihexyphenidyl Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Trihexyphenidyl Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Trihexyphenidyl Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Trihexyphenidyl Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Trihexyphenidyl Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Trihexyphenidyl Sales (K Units) by Type (2021–2026)
 Table 51. Global Trihexyphenidyl Sales (K Units) by Type (2027–2032)
 Table 52. Global Trihexyphenidyl Sales Market Share by Type (2021–2026)
 Table 53. Global Trihexyphenidyl Sales Market Share by Type (2027–2032)
 Table 54. Global Trihexyphenidyl Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Trihexyphenidyl Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Trihexyphenidyl Revenue Market Share by Type (2021–2026)
 Table 57. Global Trihexyphenidyl Revenue Market Share by Type (2027–2032)
 Table 58. Global Trihexyphenidyl Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Trihexyphenidyl Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Trihexyphenidyl Sales (K Units) by Application (2021–2026)
 Table 61. Global Trihexyphenidyl Sales (K Units) by Application (2027–2032)
 Table 62. Global Trihexyphenidyl Sales Market Share by Application (2021–2026)
 Table 63. Global Trihexyphenidyl Sales Market Share by Application (2027–2032)
 Table 64. Global Trihexyphenidyl Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Trihexyphenidyl Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Trihexyphenidyl Revenue Market Share by Application (2021–2026)
 Table 67. Global Trihexyphenidyl Revenue Market Share by Application (2027–2032)
 Table 68. Global Trihexyphenidyl Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Trihexyphenidyl Price (US$/Unit) by Application (2027–2032)
 Table 70. Natco Pharma Company Information
 Table 71. Natco Pharma Description and Business Overview
 Table 72. Natco Pharma Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Natco Pharma Trihexyphenidyl Product
 Table 74. Natco Pharma Recent Developments/Updates
 Table 75. Kawaken Fine Chemical Company Information
 Table 76. Kawaken Fine Chemical Description and Business Overview
 Table 77. Kawaken Fine Chemical Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Kawaken Fine Chemical Trihexyphenidyl Product
 Table 79. Kawaken Fine Chemical Recent Developments/Updates
 Table 80. Asia Pioneer Pharmaceuticals Company Information
 Table 81. Asia Pioneer Pharmaceuticals Description and Business Overview
 Table 82. Asia Pioneer Pharmaceuticals Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Asia Pioneer Pharmaceuticals Trihexyphenidyl Product
 Table 84. Asia Pioneer Pharmaceuticals Recent Developments/Updates
 Table 85. Olon Company Information
 Table 86. Olon Description and Business Overview
 Table 87. Olon Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Olon Trihexyphenidyl Product
 Table 89. Olon Recent Developments/Updates
 Table 90. Anugraha Chemicals Company Information
 Table 91. Anugraha Chemicals Description and Business Overview
 Table 92. Anugraha Chemicals Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Anugraha Chemicals Trihexyphenidyl Product
 Table 94. Anugraha Chemicals Recent Developments/Updates
 Table 95. RL Fine Chem Company Information
 Table 96. RL Fine Chem Description and Business Overview
 Table 97. RL Fine Chem Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. RL Fine Chem Trihexyphenidyl Product
 Table 99. RL Fine Chem Recent Developments/Updates
 Table 100. Trifarma Company Information
 Table 101. Trifarma Description and Business Overview
 Table 102. Trifarma Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Trifarma Trihexyphenidyl Product
 Table 104. Trifarma Recent Developments/Updates
 Table 105. Atom pharma Company Information
 Table 106. Atom pharma Description and Business Overview
 Table 107. Atom pharma Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Atom pharma Trihexyphenidyl Product
 Table 109. Atom pharma Recent Developments/Updates
 Table 110. Amitychem Company Information
 Table 111. Amitychem Description and Business Overview
 Table 112. Amitychem Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Amitychem Trihexyphenidyl Product
 Table 114. Amitychem Recent Developments/Updates
 Table 115. Hunan Zhongnan Pharmaceutical中南制药 Company Information
 Table 116. Hunan Zhongnan Pharmaceutical中南制药 Description and Business Overview
 Table 117. Hunan Zhongnan Pharmaceutical中南制药 Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Hunan Zhongnan Pharmaceutical中南制药 Trihexyphenidyl Product
 Table 119. Hunan Zhongnan Pharmaceutical中南制药 Recent Developments/Updates
 Table 120. Changzhou Kangpu Pharmaceutical Company Information
 Table 121. Changzhou Kangpu Pharmaceutical Description and Business Overview
 Table 122. Changzhou Kangpu Pharmaceutical Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Changzhou Kangpu Pharmaceutical Trihexyphenidyl Product
 Table 124. Changzhou Kangpu Pharmaceutical Recent Developments/Updates
 Table 125. Swiss Parenterals Company Information
 Table 126. Swiss Parenterals Description and Business Overview
 Table 127. Swiss Parenterals Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Swiss Parenterals Trihexyphenidyl Product
 Table 129. Swiss Parenterals Recent Developments/Updates
 Table 130. Enomark Company Information
 Table 131. Enomark Description and Business Overview
 Table 132. Enomark Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Enomark Trihexyphenidyl Product
 Table 134. Enomark Recent Developments/Updates
 Table 135. Fengchen Group Company Information
 Table 136. Fengchen Group Description and Business Overview
 Table 137. Fengchen Group Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Fengchen Group Trihexyphenidyl Product
 Table 139. Fengchen Group Recent Developments/Updates
 Table 140. Sandoo Pharmaceuticals and Chemicals Company Information
 Table 141. Sandoo Pharmaceuticals and Chemicals Description and Business Overview
 Table 142. Sandoo Pharmaceuticals and Chemicals Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Sandoo Pharmaceuticals and Chemicals Trihexyphenidyl Product
 Table 144. Sandoo Pharmaceuticals and Chemicals Recent Developments/Updates
 Table 145. Midas Pharma Company Information
 Table 146. Midas Pharma Description and Business Overview
 Table 147. Midas Pharma Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Midas Pharma Trihexyphenidyl Product
 Table 149. Midas Pharma Recent Developments/Updates
 Table 150. Conscientia Industrial Company Information
 Table 151. Conscientia Industrial Description and Business Overview
 Table 152. Conscientia Industrial Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 153. Conscientia Industrial Trihexyphenidyl Product
 Table 154. Conscientia Industrial Recent Developments/Updates
 Table 155. Huateng Pharma Company Information
 Table 156. Huateng Pharma Description and Business Overview
 Table 157. Huateng Pharma Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 158. Huateng Pharma Trihexyphenidyl Product
 Table 159. Huateng Pharma Recent Developments/Updates
 Table 160. Daffohils Laboratories Company Information
 Table 161. Daffohils Laboratories Description and Business Overview
 Table 162. Daffohils Laboratories Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 163. Daffohils Laboratories Trihexyphenidyl Product
 Table 164. Daffohils Laboratories Recent Developments/Updates
 Table 165. Senova Technology Company Information
 Table 166. Senova Technology Description and Business Overview
 Table 167. Senova Technology Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 168. Senova Technology Trihexyphenidyl Product
 Table 169. Senova Technology Recent Developments/Updates
 Table 170. Fortunebio Pharmaceuticals Company Information
 Table 171. Fortunebio Pharmaceuticals Description and Business Overview
 Table 172. Fortunebio Pharmaceuticals Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 173. Fortunebio Pharmaceuticals Trihexyphenidyl Product
 Table 174. Fortunebio Pharmaceuticals Recent Developments/Updates
 Table 175. Taj Pharmaceuticals Company Information
 Table 176. Taj Pharmaceuticals Description and Business Overview
 Table 177. Taj Pharmaceuticals Trihexyphenidyl Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 178. Taj Pharmaceuticals Trihexyphenidyl Product
 Table 179. Taj Pharmaceuticals Recent Developments/Updates
 Table 180. Key Raw Materials Lists
 Table 181. Raw Materials Key Suppliers Lists
 Table 182. Trihexyphenidyl Distributors List
 Table 183. Trihexyphenidyl Customers List
 Table 184. Trihexyphenidyl Market Trends
 Table 185. Trihexyphenidyl Market Drivers
 Table 186. Trihexyphenidyl Market Challenges
 Table 187. Trihexyphenidyl Market Restraints
 Table 188. Research Programs/Design for This Report
 Table 189. Key Data Information from Secondary Sources
 Table 190. Key Data Information from Primary Sources
 Table 191. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Trihexyphenidyl
 Figure 2. Global Trihexyphenidyl Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Trihexyphenidyl Market Share by Type: 2025 & 2032
 Figure 4. 2mg Product Picture
 Figure 5. 5mg Product Picture
 Figure 6. Global Trihexyphenidyl Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Trihexyphenidyl Market Share by Application: 2025 & 2032
 Figure 8. Hospital
 Figure 9. Pharmacy
 Figure 10. Clinic
 Figure 11. Global Trihexyphenidyl Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Trihexyphenidyl Market Size (US$ Million), 2021–2032
 Figure 13. Global Trihexyphenidyl Sales (K Units), 2021–2032
 Figure 14. Global Trihexyphenidyl Average Price (US$/Unit), 2021–2032
 Figure 15. Trihexyphenidyl Report Years Considered
 Figure 16. Trihexyphenidyl Sales Share by Manufacturers in 2025
 Figure 17. Global Trihexyphenidyl Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Trihexyphenidyl Players: Market Share by Revenue in Trihexyphenidyl in 2025
 Figure 19. Trihexyphenidyl Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Trihexyphenidyl Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Trihexyphenidyl Sales Market Share by Country (2021–2032)
 Figure 22. North America Trihexyphenidyl Revenue Market Share by Country (2021–2032)
 Figure 23. United States Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Trihexyphenidyl Sales Market Share by Country (2021–2032)
 Figure 26. Europe Trihexyphenidyl Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Trihexyphenidyl Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Trihexyphenidyl Revenue Market Share by Region (2021–2032)
 Figure 34. China Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Trihexyphenidyl Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Trihexyphenidyl Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Trihexyphenidyl Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Trihexyphenidyl Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Trihexyphenidyl Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Trihexyphenidyl by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Trihexyphenidyl by Type (2021–2032)
 Figure 54. Global Trihexyphenidyl Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Trihexyphenidyl by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Trihexyphenidyl by Application (2021–2032)
 Figure 57. Global Trihexyphenidyl Price (US$/Unit) by Application (2021–2032)
 Figure 58. Trihexyphenidyl Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure